HHS expands buprenorphine access

Buprenorphine.

HHS/CDC Legal Response to SARS Outbreak

Before the severe acute respiratory syndrome (SARS) outbreak, the Centers for Disease Control and Prevention's (CDC) legal authority to apprehend, detain, or conditionally release persons was limited to seven listed diseases, not including SARS, and could only be changed using a two-step process: 1) executive order of the President of the United States on recommendation by the Secretary, U.S. D...

Buprenorphine

In the crystal structure of a semi-synthetic opioid drug buprenorphine, C29H41NO4 {systematic name: (2S)-2-[(5R,6R,7R,14S)-9α-cyclo-propyl-methyl-3-hy-droxy-6-meth-oxy-4,5-ep-oxy-6,14-ethano-morphinan-7-yl]-3,3-di-methyl-butan-2-ol}, the cyclo-propyl-methyl group is disordered over two sites with an occupancy factor of 0.611 (3) for the major component. One of the hy-droxy groups is involved in...

Part 36—indemnification of Hhs Employees

(1) A new precedent or a new point of law is involved; or (2) A question of policy is or may be involved; or (3) The United States is or may be entitled to indemnity or contribution from a third party and the Department is unable to adjust the third party claim; or (4) The compromise of a particular claim, as a practical matter, will or may control the disposition of a related claim in which th...

Health Care Reform Bill Expands Access to Section 340B Discounted Drugs for Hospitals.

ally 25% to 40% of the average manufacturer’s price (AMP). That differential goes into the hospital’s pocket, totaling as much as $10 million per year for some larger hospital systems. That dab of honey on the bottom line of a safety net hospital (or federal clinic) is especially sweet these days, with public hospitals beset by state cutbacks in Medicaid funding at the same time that their unco...